Director/PDMR Shareholding

RNS Number : 6882O

e-Therapeutics plc

22 August 2017

E-THERAPEUTICS PLC

("e-therapeutics" or the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS

DISCHARGING MANAGERIAL RESPONSIBILITIES

Oxford, UK, 22 August 2017 - e-therapeutics plc (AIM: ETX), the computer-based drug discovery platform company, announces that it has received notifications from two of its directors that they have purchased, in aggregate, 520,000 shares in the Company at a price of 10.6 pence per share. The purchases took place today.

The number of ordinary shares purchased by each director is set out below:

Director	Number of shares purchased
Iain Ross	250,000
Ray Barlow	270,000

Mr Ross purchased the shares through his self-invested personal pension (SIPP) and, following these trades, the beneficial interests of those directors in ordinary shares of ETX are as follows:

Director	Number of shares held	Percentage of issued share capital
Iain Ross	1,250,000	0.47%
Ray Barlow	1,100,000	0.41%

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further details:

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Iain Ross
2	Reason for the notification
a)	Position/status	Non-Executive Chairman
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	e-therapeutics plc
b)	LEI	21380049RHSSJXWKYT18
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.1 pence ISIN: GB00B2823H99
b)	Nature of the transaction	Purchase of shares through self-invested personal pension (SIPP)
c)	Price(s) and volume(s)	250,000 ordinary shares at a price of 10.6 pence per share
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	22 August 2017
f)	Place of the transaction	London Stock Exchange, AIM (XLON)

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Ray Barlow
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	e-therapeutics plc
b)	LEI	21380049RHSSJXWKYT18
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.1 pence ISIN: GB00B2823H99
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	270,000 ordinary shares at a price of 10.6 pence per share
d)	Aggregated information - Aggregated volume - Price	N/A
e)	Date of the transaction	22 August 2017
f)	Place of the transaction	London Stock Exchange, AIM (XLON)